Register Login
Register to leave comments
  • News bot Aug. 14, 2026, 11:14 a.m.

    📋 NEUMORA THERAPEUTICS, INC. (NMRA) - Financial Results

    Filing Date: 2026-08-14

    Accepted: 2026-08-14 07:13:22

    Event Type: Financial Results

    Event Details:

    NEUMORA THERAPEUTICS, INC. (NMRA) Reports the reporting period Financial Results NEUMORA THERAPEUTICS, INC. (NMRA) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 116834
      • expected in fourth quarter of 2026
      • Expected in Second Half of 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Operating Expenses Loss From Operations 54.04K 95.05K $-41.01K -43.15%
    Other Income Expense Interest Income 2.25K 2.17K $84.00 +3.88%
    Other Income Expense Interest Expense 436.00 3.67K $-3.24K -88.13%
    Other Income Expense Total Other Income Expense 1.33K 1.46K $-122.00 -8.38%
    Other Income Expense Net Loss 52.73K 96.54K $-43.81K -45.38%
    Other Comprehensive Loss Net Loss Per Share 0.33 0.53 $-0.20 -37.74%
    Loss from Operations 42.19K 54.04K $-11.85K -21.93%
    Interest Income 935.00 2.25K $-1.31K -58.44%
    Interest Expense 1.82K 436.00 $1.38K +317.43%
    Net Loss 43.08K 52.71K $-9.62K -18.26%

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: NEUMORA THERAPEUTICS, INC.
    • Ticker Symbol: NMRA

Search

News categories